The scientific founder of CellOrigin. Dr. Zhang Jin is a PI researcher at Zhejiang University School of Medicine. He received his Ph.D. from the University of California, Los Angeles in 2011, and completed postdoctoral research in the George Daley laboratory of Harvard Medical School/Boston Children's Hospital from 2012 to 2017. Served as a scientist at Amgen Inc. and led the team to establish an iPS platform for the discovery of new drug targets. His current research fields are: 1) Application of stem cell technology to immunotherapy; 2) Metabolic regulation of cell fate; 3) Establishment of iPS disease model. His papers published in Cell Stem Cell, Cell Metabolism, Genome Biology, Cell Report, EMBO J., Journal of Hematology and Oncology and other top journals have been cited more than 2000 times.